EC Orthopaedics

Editorial Volume 17 Issue 1 - 2026

Bone Tumors and Metastasis, Diagnostic Promotion

Da-Yong Lu* and Jin-Yu Che

School of Life Sciences, Shanghai University, Shanghai, PR China

*Corresponding Author: Da-Yong Lu, School of Life Sciences, Shanghai University, Shanghai, PR China.
Received: November 05, 2025; Published: December 29, 2025




Bone cancer and metastasis need extensive care. Plenty of cancer patients suffer from bone metastasis. Facing critical challenges, disease diagnosis and treatment need evergrowing techniques. To promote therapeutics, overall situations are addressed in this editorial.

 Keywords: Bone Cancer; Neoplasm Metastasis; Drug Treatment; Clinical Diagnosis

  1. Lambert AW., et al. “Emerging biological principles of metastasis”. Cell 4 (2017): 670-691.
  2. Ahmad AS., et al. “Trends in the lifetime risk of developing cancer in Great Britain Comparison of risk for those born from 1930-1960”. British Journal of Cancer 5 (2015): 943-947.
  3. Lu DY and Lu TR. “Antimetastatic drugs, pharmacologic challenge and opportunity”. Current Drug Therapy2 (2025): 169-179.
  4. Gerstberger S., et al. “Metastasis”. Cell8 (2023): 1564-1579.
  5. Lu DY and Xu B. “Bone metastasis treatment, major frontiers”. Acta Scientific Orthopaedics7 (2021): 1-2.
  6. Hakim BAA. “Benign bone tumors, an overview”. Acta Scientific Orthopaedics10 (2021): 1-2.
  7. Lu DY and Xu B. “Bone cancer and metastatic trials, drug treatment”. Acta Scientific Orthopaedics9 (2021): 31-33.
  8. Lu DY., et al. “Cancer Metastasis treatments”. Current Drug Therapy1 (2013): 24-29.
  9. Bhadresha KP., et al. “A predictive biomarker panel for bone metastasis, liquid biopsy approach”. Journal of Bone Oncology 29 (2021): 100371.
  10. Pantel K and Alix-Panabieres C. “Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation”. Journal for ImmunoTherapy of Cancer 12 (2022): e005615.
  11. Lu DY. “Advances in cancer therapeutics and genomics for improved patient outcomes”. Current Cell Science 1 (2026): 43-46.
  12. Lu DY and Che JY. “Possible ways of bone pain alleviation”. EC Orthopedics5 (2025): 1-4.
  13. Lu DY and Xu B. “Cancer bone metastasis, experimental study”. Acta Scientific Orthopeadics12 (2022): 1-3.
  14. Lu DY., et al. “Anti-metastatic drug development, work out towards new direction”. Medicinal Chemistry7 (2018): 512.
  15. Lu DY., et al. “Drug sensitivity testing for cancer therapy, key areas”. Reviews on Recent Clinical Trials4 (2022): 291-299.
  16. Volm M and Efferth T. “Prediction of cancer drug resistance and implications for personalized medicine”. Frontiers in Oncology 5 (2015): 282.
  17. Lu DY and Lu TR. “Drug sensitivity testing, a unique drug selection strategy”. Advances in Biomarker Sciences and Technology 2 (2020): 59-66.
  18. Lu DY., et al. “Cancer bioinformatics for update anticancer drug developments and personalized therapeutics”. Reviews on Recent Clinical Trials2 (2017): 101-110.
  19. Montero J., et al. “Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy”. Cell5 (2015): 977-989.
  20. Popova AA and Levkin PA. “Precision medicine in oncology: In vitro drug sensitivity and resistance test (DSRT) for selection of personalized anticancer therapy”. Advanced Therapeutics 2 (2020): 1900100.
  21. Zhang Y., et al. “Anticancer drug sensitivity assay with quantitative heterogeneity testing using single-cell Raman Spectroscope”. Molecules11 (2018): 2903.
  22. Wang JK., et al. “In vitro anticancer drug sensitivity sensing through single-cell Raman Spectroscopy”. Biosensors8 (2021): 286.
  23. Pantano F., et al. “Integrin alpha 5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions”. Oncogene7 (2021): 1284-1299.
  24. Lu DY and Che JY. “Bone disease treatments, importance of technical supports”. Acta Scientific Orthopaedics4 (2021): 55-57.
  25. Lu DY and Lu TR. “Personalized oncology: scientific and technical approaches”. Current Cell Science1 (2025): 57-66.
  26. Lu DY., et al. “Individualized cancer therapy, future approaches”. Current Pharmacogenomics and Personalized Medicine2 (2018): 156-163.
  27. Barani M., et al. “Recent advances in nanotechnology-based diagnosis and treatments of human osteosarcoma”. Biosensors2 (2021): 55.
  28. Lu DY., et al. “Bone metastasis and circulation biomarkers profiling toward personalized cancer medicine”. BME Horizon3 (2023): 91.
  29. Lu DY and Che JY. “Bone metastasis diagnosis, blood biomarker detections”. Biomedical Journal of Scientific and Technical Research 4 (2023): 8276.

Da-Yong Lu and Jin-Yu Che. “Bone Tumors and Metastasis, Diagnostic Promotion”. EC Orthopaedics  17.1 (2026): 01-03.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net